IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Aesica partners with Durham and Leeds universities to commercialize API manufacturing technology

7:35 AM MST | December 18, 2012 | Deepti Ramesh

Aesica Pharmaceuticals (Newcastle upon Tyne, UK), the University of Durham (Durham, UK), and the University of Leeds (Leeds, UK) were jointly awarded the METRC innovation grant to investigate and accelerate the development of processes that will improve cost efficiencies and increase manufacturing capacity at Aesica’s Cramlington, UK, site. The new partnership with the University of Durham and the University of Leeds will aim to develop new or improved routes for the manufacture of an active pharmaceutical ingredient (API), Aesica says. A detailed kinetic...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa